References
Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Kostler H, Hecker H, Burchert W (2004). Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79
Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, Bower RH, Mabry CD, Leevy CM, Kiernan T (1985) Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr 9:288–295
Cooper AJ, McDonald JM, Gelbard AS, Gledhill RF, Duffy TE (1979) The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem 254:4982–4992
Eriksson LS, Conn HO (1989) Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology 10:228–246
Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F (1974) Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 127:40–47
Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB (1976) The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77–91
Gjedde A, Lockwood AH, Duffy TE, Plum F (1978) Cerebral blood flow and metabolism in chronically hyperammonemic rats: effect of an acute ammonia challenge. Ann Neurol 3:325–330
Gratton JA, Abraham MH, Bradbury MW, Chadha HS (1997) Molecular factors influencing drug transfer across the blood–brain barrier. J Pharm Pharmacol 49:1211–1216
Harmar AJ, Horn AS (1976) Octopamine in mammalian brain: rapid post mortem increase and effects of drugs. J Neurochem 26:987–993
Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H (2006) Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 43:42–50
Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, Plum F (1979) The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 63:449–460
Lockwood AH, Finn RD, Campbell JA, Richman TB (1980) Factors that affect the uptake of ammonia by the brain: the blood–brain pH gradient. Brain Res 181:259–266
Lockwood AH, Yap EW, Wong WH (1991) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 11:337–341
Michel H, Solere M, Granier P, Cauvet G, Bali JP, Pons F, Bellet-Herman H (1980) Treatment of cirrhotic hepatic encephalopathy with L-DOPA, a controlled trial. Gastroenterology 79:207
Michel H, Bories P, Aubin JP, Pomier Layrargues G, Bauret P, Bellet Herman H (1985) Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients. Liver 5:282–289
Phelps ME, Hoffman EJ, Raybaud C (1977) Factors which affect cerebral uptake and retention of 13NH3. Stroke 8:694–702
Raichle ME, Larson KB (1981) The significance of the NH3–\( {\text{NH}}^{{\text{ + }}}_{{\text{4}}} \) equilibrium on the passage of 13N–ammonia from blood to brain. Circ Res 48:913–937
Sørensen M, Keiding S (2006) Response to Lockwood and Wack: The brain permeability-surface product for ammonia. Hepatology 43:1053–1056
Uribe M, Garcia-Ramos G, Ramos M, Valverde C, Marquez MA, Farca A, Guevara L (1983) Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy. Am J Gastroenterol 78:517–522
Wahren K, Denis J, Desurmont P, Eriksson LS, Escoffier J-M, Gauthier AP, Hagenfeldt L, Michel H, Opolon P, Paris J-C, Veyrac M (1983) Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 3:475–480
Zieve L, Olsen RL (1977) Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine? Gut 18:688–691
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lockwood, A.H. Controversies in ammonia metabolism: implications for hepatic encephalopathy. Metab Brain Dis 22, 285–289 (2007). https://doi.org/10.1007/s11011-007-9059-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-007-9059-0